Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Jan;67(1):118-21.
doi: 10.1001/archneurol.2009.299.

Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis

Affiliations
Case Reports

Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis

Mary Kurian et al. Arch Neurol. 2010 Jan.

Abstract

Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis has been recently reported as autoimmune/paraneoplastic encephalitis, affecting mostly young females.

Objective: To describe opsoclonus-myoclonus syndrome in association with anti-NMDAR antibodies.

Design: Case report.

Setting: Geneva University Hospital. Patient A 23-year-old woman with opsoclonus-myoclonus syndrome.

Results: Two weeks after an episode of gastroenteritis, the patient developed symptoms of depression associated with psychomotor slowing, progressive gait instability, and opsoclonus-myoclonus. Cerebrospinal fluid examination showed mild lymphocytic pleocytosis and intrathecal IgG synthesis with oligoclonal bands. The patient's condition worsened rapidly to an akinetic mutism, followed by a period of agitation, delirium, and hallucinations. These gradually subsided; however, a frontal behavior and executive dysfunction persisted 5 months after symptom presentation. No tumor was found. Anti-NMDAR antibodies were found in the cerebrospinal fluid.

Conclusions: Opsoclonus-myoclonus may occur in patients with anti-NMDAR encephalitis. Prompt diagnosis of this disorder is important because after tumor removal and immunomodulatory therapies it has a relatively good prognosis.

PubMed Disclaimer

Figures

Figure
Figure
Electroencephalography of a 23-year-old woman with opsoclonus-myoclonus syndrome. A, Recording on day 10 shows bursts of diffuse delta activity on a background of theta rhythm. The first marker indicates eye closure; the second marker, eye opening. B, Recording on day 60 shows a normal alpha activity with ocular artifacts in the frontopolar leads; the electrocardiogram shows tachycardia (100 beats/min). The marker indicates eye closure.

Comment in

Similar articles

Cited by

References

    1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091–1098. - PMC - PubMed
    1. Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol. 2003;53(3):347–353. - PubMed
    1. Markakis I, Alexiou E, Xifaras M, Gekas G, Rombos A. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin Neurol Neurosurg. 2008;110(6):619–621. - PubMed
    1. Fitzpatrick AS, Gray OM, McConville J, McDonnell GV. Opsoclonus myoclonus syndrome associated with benign ovarian teratoma. Neurology. 2008;70(15):1292–1293. - PubMed
    1. Shindo A, Kagawa K, Ii Y, Sasaki R, Kokubo Y, Kuzuhara S. Anti-N-methyl-D-aspartate receptor-related grave but reversible encephalitis with ovarian teratoma in 2 Japanese women presenting with excellent recovery without tumor resection. Eur Neurol. 2009;61(1):50–51. - PubMed

Publication types

MeSH terms